Oragenics
OGEN
16 hedge funds and large institutions have $161K invested in Oragenics in 2025 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 6 closing their positions.
11% less funds holding
Funds holding: 18 → 16 (-2)
11.74% less ownership
Funds ownership: 14.71% → 2.97% (-12%)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
52% less capital inflows, than outflows
Capital inflows: $153K | Capital outflows: $321K
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DRW Securities
Chicago,
Illinois
|
+$78.2K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$74.5K |
| 3 |
Allworth Financial
Folsom,
California
|
+$422 |
| 4 |
BlackRock
New York
|
+$3 |
| 5 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
+$1 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Clear Street
New York
|
-$270K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$19.6K |
| 3 |
Morgan Stanley
New York
|
-$14.9K |
| 4 |
FNY Investment Advisers
New York
|
-$9K |
| 5 |
JP Morgan Chase
New York
|
-$2.6K |
OGEN Hedge Fund Activity: Q3 2025 in Review
16 of the 7,650 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q3 2025, worth a combined $161K — down 60% from $402K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of OGEN and 4 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 1 added.
The largest buyer was DRW Securities, opening a new position worth an estimated $78.2K. The largest seller was Clear Street, exiting entirely with an estimated $270K sold.
- 16 institutional investors held Oragenics (OGEN) as of Q3 2025, down from 18 in Q2 2025.
- Funds reported $161K of Oragenics stock for Q3 2025, down 60% quarter-over-quarter.
- 4 funds opened new Oragenics positions in Q3 2025 and 6 closed out, a net change of -2 holders.
- The largest Oragenics buyer in Q3 2025 was DRW Securities, an estimated $78.2K added.
- The largest Oragenics seller in Q3 2025 was Clear Street, an estimated $270K sold.
Based on aggregated 13F filings for Q3 2025.